Truist raised the firm’s price target on Udemy to $15 from $13 and keeps a Buy rating on the shares. The stock is at a depressed valuation level that makes little sense considering the stability in the business, UB market leadership, improving margin and profit prospects, along with the company’s “key growth catalysts”, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on UDMY:
- Udemy price target raised to $15 from $13 at KeyBanc
- Udemy price target raised to $16 from $14 at BofA
- Udemy Named to Built In’s Annual List of Best Places to Work in 2024
- Udemy to Present at Needham’s 2024 Annual Growth Conference
- Accolade named 2024 Digital Health Top Pick, added to Conviction List at Needham